The response of psoriasis to betamethasone valerate and clobetasol propionate.
- 1 March 1976
- journal article
- clinical trial
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 94 (s12) , 89-92
- https://doi.org/10.1111/j.1365-2133.1976.tb02275.x
Abstract
Twelve patients with symmetrical psoriasis were studied for a period of 6 months. Clobetasol propionate 0-05% ointment was applied to the lesions on one side and betamethasone valerate 0-1% ointment to those on the other side as a double-blind controlled trial of these two treatments. All the patients showed a relative improvement on the side treated with clobetasol propionate. Clobetasol propionate-treated lesions tended to clear for longer than the corresponding betamethasone valerate treated lesions. The condition of five of the patients was better at the end of the study period than at the beginning.Keywords
This publication has 6 references indexed in Scilit:
- Cushing's syndrome and pituitary-adrenal suppression due to clobetasol propionate.BMJ, 1975
- The effect on plasma corticosteroid levels of the short term topical application of clobetasol propionateBritish Journal of Dermatology, 1974
- Complications of topical corticosteroid therapy in patients with liver diseaseBritish Journal of Dermatology, 1974
- The clinical evaluation of a new topical corticosteroid, clobetasol propionate.British Journal of Dermatology, 1974
- PITUITARY-ADRENAL FUNCTION AFTER OCCLUSIVE TOPICAL THERAPY WITH BETAMETHASONE-17-VALERATEThe Lancet, 1967
- BETAMETHASONE 17-VALERATE: A NEW TOPICAL CORTICOSTEROIDThe Lancet, 1964